STOCK TITAN

GEVO SEC Filings, May-Jun 2026

GEVO NASDAQ

Gevo, Inc. filings document the company’s renewable-fuels business, Nasdaq-listed common stock, operating results and material corporate events. Form 8-K reports include quarterly and annual financial results, business updates for low-carbon ethanol, carbon management, synthetic aviation fuel initiatives, and material financing or refinancing arrangements involving company subsidiaries.

Proxy and governance filings cover director elections, board composition, auditor ratification, executive compensation votes and officer transitions. The filing record also documents credit agreements, working-capital facilities, renewable natural gas project debt matters, compensatory arrangements and other disclosures related to Gevo’s capital structure, governance and project-development strategy.

Rhea-AI Summary

Gevo, Inc. CEO Paul D. Bloom reported an open-market sale of 35,189 shares of common stock on June 12, 2026 at a weighted average price of $1.4252 per share. According to the disclosure, these shares were sold to cover tax withholding obligations when a restricted stock award vested, and the trades were carried out under a pre-arranged Rule 10b5-1 trading plan adopted on December 22, 2025.

After the transactions, Bloom directly holds 1,483,399 shares of Gevo common stock and indirectly holds 28,123.5100 shares through a 401(k) plan.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.40%
Tags
insider
-
Rhea-AI Summary

GEVO submitted a Form 144 notice for the proposed sale of 63,028 shares of Common Stock tied to Restricted Stock Awards, dated 06/12/2026. The filing also records a prior sale of 31,958 shares by Oluwagbemileke Yusuf Agiri on 05/27/2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.14%
Tags
other
-
Rhea-AI Summary

Gevo, Inc. (GEVO) lists Officer Paul Bloom’s proposed sale of 35,189 common shares, with an aggregate market value of $50,151.36 and an approximate sale date of June 12, 2026. Stifel Nicolaus & Company Inc. is named as the broker. The notice records a Rule 10b5-1 plan adoption or instruction date of December 22, 2025, and states that Bloom acquired 70,028 shares through restricted stock awards from the issuer on June 9, 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.14%
Tags
other
Rhea-AI Summary

Gevo, Inc. officer Kimberly T. Bowron filed a notice covering a proposed sale of 15,470 shares of common stock, with an aggregate market value of $22,047.84 and an approximate sale date of June 12, 2026. The form reports that 38,515 shares were acquired from the issuer as restricted stock awards on June 9, 2026. It also lists a sale of 25,101 shares on May 27, 2026, for gross proceeds of $44,173.00, and gives November 20, 2025, as the Rule 10b5-1 plan adoption or instruction date.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.14%
Tags
other
-
Rhea-AI Summary

Gevo, Inc. Officer Andrew Shafer reported a proposed sale of 9,443 common shares, with an aggregate market value of $13,458.16 and an approximate sale date of June 12, 2026. Stifel Nicolaus & Company Inc. is listed as the broker. The securities information lists 18,576 shares acquired from the issuer through restricted stock awards on June 9, 2025. It lists November 19, 2025 as the plan-adoption or instruction date if relying on Rule 10b5-1.

The notice also lists sales of 5,550 shares on April 1, 2026 for gross proceeds of $15,027.00; 5,550 shares on May 1, 2026 for $11,103.00; and 32,667 shares on May 27, 2026 for $57,487.00.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.14%
Tags
other
-
Rhea-AI Summary

Gevo, Inc. (GEVO) is identified as the issuer in a notice naming Officer Ryan Christopher Michael as the person for whose account a proposed sale of 35,196 common shares is reported. The proposed sale has an aggregate market value of $50,161.34 and an approximate sale date of June 12, 2026. The notice records November 19, 2025 as the Rule 10b5-1 plan adoption or instruction date.

The separate three-month sales history names seller Christopher Ryan and lists sales of 100,000 shares on March 30, 2026, 29,797 shares on March 31, 2026, and 87,700 shares on May 27, 2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.14%
Tags
other
Rhea-AI Summary

GEVO filed a Form 144 notice reporting 157,563 shares of Common Stock described as Restricted Stock Awards tied to equity compensation listed for sale as of 06/12/2026.

The filing also discloses a prior sale by Patrick Gruber of 186,469 shares on 05/27/2026 with proceeds shown as $328,148.00.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.14%
Tags
other
-
Rhea-AI Summary

Gevo, Inc. officer Lindsay Fitzgerald gave notice of a proposed sale of 12,436 common shares, with an aggregate market value of $17,723.79 and an approximate sale date of June 12, 2026. Stifel Nicolaus & Company Inc. is identified as the broker, and the Rule 10b5-1 plan adoption date is December 1, 2025. The securities information reports 28,011 common shares acquired from the issuer through restricted stock awards on June 9, 2025. Fitzgerald’s past sales listed are 20,000 shares on March 12, 2026, for gross proceeds of $50,124.00, and 9,754 shares on May 27, 2026, for gross proceeds of $17,165.00.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.14%
Tags
other
-
Rhea-AI Summary

Mize Gary W. reported acquisition or exercise transactions in this Form 4 filing.

Gevo, Inc. director Gary W. Mize received a grant of 70,000 shares of common stock, reported as a stock award with no cash price per share. Following this grant, he directly holds 351,226 shares of Gevo common stock.

The grant is structured as restricted common stock that will vest on the earlier of the next annual meeting of stockholders or the first anniversary of the grant date, if he remains in continuous service with Gevo through the vesting date.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.08%
Tags
insider
Rhea-AI Summary

Marsh Andrew reported acquisition or exercise transactions in this Form 4 filing.

Gevo, Inc. director Andrew Marsh received a grant of 70,000 shares of restricted common stock, awarded at $0.0000 per share as compensation. These shares vest on the earlier of the next annual meeting of stockholders or the first anniversary of the grant date, if he remains in continuous service. Following this award, Marsh directly holds 343,669 shares of common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.08%
Tags
insider

FAQ

How many Gevo (GEVO) SEC filings are available on StockTitan?

StockTitan tracks 170 SEC filings for Gevo (GEVO), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Gevo (GEVO)?

The most recent SEC filing for Gevo (GEVO) was filed on November 10, 2026.